NDC 15631-0540

BLATTA ORIENTALIS

Blatta Orientalis

BLATTA ORIENTALIS is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Rxhomeo Private Limited D.b.a. Rxhomeo, Inc. The primary component is Blatta Orientalis.

Product ID15631-0540_bb0b61dc-fde6-4b59-8fe6-23b53764c7de
NDC15631-0540
Product TypeHuman Otc Drug
Proprietary NameBLATTA ORIENTALIS
Generic NameBlatta Orientalis
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2015-12-30
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameRxhomeo Private Limited d.b.a. Rxhomeo, Inc
Substance NameBLATTA ORIENTALIS
Active Ingredient Strength2 [hp_X]/1
NDC Exclude FlagE
Listing Certified Through2018-12-31

Packaging

NDC 15631-0540-7

10000 TABLET in 1 CONTAINER (15631-0540-7)
Marketing Start Date2015-12-30
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 15631-0540-0 [15631054000]

BLATTA ORIENTALIS TABLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-12-30
Inactivation Date2020-01-31

NDC 15631-0540-2 [15631054002]

BLATTA ORIENTALIS TABLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-12-30
Inactivation Date2020-01-31

NDC 15631-0540-4 [15631054004]

BLATTA ORIENTALIS TABLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-12-30
Inactivation Date2020-01-31

NDC 15631-0540-7 [15631054007]

BLATTA ORIENTALIS TABLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-12-30
Inactivation Date2020-01-31

NDC 15631-0540-6 [15631054006]

BLATTA ORIENTALIS TABLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-12-30
Inactivation Date2020-01-31

NDC 15631-0540-1 [15631054001]

BLATTA ORIENTALIS TABLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-12-30
Inactivation Date2020-01-31

NDC 15631-0540-3 [15631054003]

BLATTA ORIENTALIS TABLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-12-30
Inactivation Date2020-01-31

NDC 15631-0540-5 [15631054005]

BLATTA ORIENTALIS TABLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-12-30
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
BLATTA ORIENTALIS2 [hp_X]/1

OpenFDA Data

SPL SET ID:31bc79e7-e1f1-4be2-af32-67338a81d6b6
Manufacturer
UNII
UPC Code
  • 8907460005526
  • NDC Crossover Matching brand name "BLATTA ORIENTALIS" or generic name "Blatta Orientalis"

    NDCBrand NameGeneric Name
    0220-0868Blatta orientalisBLATTA ORIENTALIS
    0220-0869Blatta orientalisBLATTA ORIENTALIS
    0220-0871Blatta orientalisBLATTA ORIENTALIS
    0220-0872Blatta orientalisBLATTA ORIENTALIS
    0220-0873Blatta orientalisBLATTA ORIENTALIS
    15631-0083BLATTA ORIENTALISBLATTA ORIENTALIS
    15631-0540BLATTA ORIENTALISBLATTA ORIENTALIS
    63545-499Blatta OrientalisBlatta Orientalis
    63545-500Blatta OrientalisBlatta Orientalis
    63545-501Blatta OrientalisBlatta Orientalis
    63545-502Blatta OrientalisBlatta Orientalis
    63545-503Blatta OrientalisBlatta Orientalis
    63545-504Blatta OrientalisBlatta Orientalis
    63545-505Blatta OrientalisBlatta Orientalis
    68428-259Blatta orientalisBLATTA ORIENTALIS
    71919-125Blatta orientalisBLATTA ORIENTALIS
    69152-1020Blatta orientalis 30CBlatta orientalis
    64117-117CoughBLATTA ORIENTALIS

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.